← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT04832009

Reversing Glucose and Lipid-mediated Vascular Dysfunction

Trial Parameters

Condition Blood Pressure
Sponsor University of Kansas Medical Center
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 46
Sex ALL
Min Age 18 Years
Max Age 79 Years
Start Date 2022-05-09
Completion 2026-08-01
Interventions
Dextrose 20 % in 500 ML InjectionIntralipidSaline

Brief Summary

The purpose of our study is to understand the extent to which the blood vessels are affected by glucose and fat (lipids) in lean healthy adults and if these changes in the blood vessels contribute to the development of high blood pressure.

Eligibility Criteria

Inclusion Criteria: * Lean: BMI \< 25 kg/m * Normal insulin sensitivity: (calculation based on fasting glucose and insulin concentrations in blood) * Middle-aged: 18-79 years * Blood pressure: \< 140 (systolic) and \< 90 mmHg (diastolic * Weight stable (+/- 5 lbs) for the previous 3 months * Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior. * Able and willing to provide written informed consent Exclusion Criteria: * Diabetes mellitus Type I or Type II: fasting glucose \< 126 mg/dL and/or HbA1c \< 6.5% * Current smoker or History of smoking in the past 3 months. * Hyperlipidemia: Fasting triglycerides \< 250 mg/dL * Hypertension: \>130/80 mmHg * History of heart disease (e.g., myocardial infarction, stent, heart attack, stroke, heart failure, valvular heart disease, cardiomyopathy) * History of vascular disease (e.g., bypass, stroke)

Related Trials